129 related articles for article (PubMed ID: 24147733)
1. Defining variation in urinary oxalate in hyperoxaluric stone formers.
Antonelli JA; Langman CB; Odom C; Poindexter J; Huet B; Pearle MS
J Endourol; 2013 Dec; 27(12):1530-4. PubMed ID: 24147733
[TBL] [Abstract][Full Text] [Related]
2. Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria.
D'Costa MR; Kausz AT; Carroll KJ; Ingimarsson JP; Enders FT; Mara KC; Mehta RA; Lieske JC
Nephrol Dial Transplant; 2021 Dec; 36(12):2208-2215. PubMed ID: 33367720
[TBL] [Abstract][Full Text] [Related]
3. Etiology, urine metabolic risk factors, and urine oxalate patterns in patients with significant hyperoxaluria and recurrent nephrolithiasis.
Moore JP; Mauler DJ; Narang GL; Stern KL; Humphreys MR; Keddis MT
Int Urol Nephrol; 2022 Nov; 54(11):2819-2825. PubMed ID: 35917078
[TBL] [Abstract][Full Text] [Related]
4. ALLN-177, oral enzyme therapy for hyperoxaluria.
Lingeman JE; Pareek G; Easter L; Pease R; Grujic D; Brettman L; Langman CB
Int Urol Nephrol; 2019 Apr; 51(4):601-608. PubMed ID: 30783888
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
Baggio B; Gambaro G; Favaro S; Borsatti A
Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
[TBL] [Abstract][Full Text] [Related]
6. Oxalate status in stone-formers. Two distinct hyperoxaluric entities.
Hatch M
Urol Res; 1993 Jan; 21(1):55-9. PubMed ID: 8456539
[TBL] [Abstract][Full Text] [Related]
7. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
Osther PJ
Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
[TBL] [Abstract][Full Text] [Related]
8. Re: defining variation in urinary oxalate in hyperoxaluric stone formers.
Assimos DG
J Urol; 2014 Jun; 191(6):1811-2. PubMed ID: 25280291
[No Abstract] [Full Text] [Related]
9. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
10. The urinary response to an oral oxalate load in recurrent calcium stone formers.
Krishnamurthy MS; Hruska KA; Chandhoke PS
J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
[TBL] [Abstract][Full Text] [Related]
12. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
[TBL] [Abstract][Full Text] [Related]
13. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
Jaeger P; Portmann L; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
[TBL] [Abstract][Full Text] [Related]
14. Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.
Kaelin A; Casez JP; Jaeger P
Urol Res; 2004 Feb; 32(1):61-8. PubMed ID: 14628106
[TBL] [Abstract][Full Text] [Related]
15. Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1.
Sas DJ; Mara K; Mehta RA; Seide BM; Banks CJ; Danese DS; McGregor TL; Lieske JC; Milliner DS
Pediatr Nephrol; 2024 Jan; 39(1):141-148. PubMed ID: 37458799
[TBL] [Abstract][Full Text] [Related]
16. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.
Perinpam M; Enders FT; Mara KC; Vaughan LE; Mehta RA; Voskoboev N; Milliner DS; Lieske JC
Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria.
Goldfarb DS; Modersitzki F; Asplin JR
Clin J Am Soc Nephrol; 2007 Jul; 2(4):745-9. PubMed ID: 17699491
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
Curhan GC; Willett WC; Speizer FE; Stampfer MJ
Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
Penniston KL; Nakada SY
Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
[TBL] [Abstract][Full Text] [Related]
20. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria.
Takei K; Ito H; Masai M; Kotake T
Urol Int; 1998; 61(3):192-5. PubMed ID: 9933846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
